Dallas, TX, United States of America

Erik Lykken

This inventor holds 1 USPTO granted patent. Top assignees: The University of North Carolina at Chapel Hill, University of Pennsylvania. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erik Lykken. Retrieved from https://idiyas.com/inventor/erik-lykken

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Erik Lykken

Introduction

Erik Lykken is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of genetics, particularly in the development of therapies for genetic disorders. His work focuses on optimizing gene expression to address critical health issues.

Latest Patents

Lykken holds a patent for "Optimized GALC genes and expression cassettes and their use." This invention relates to polynucleotides that comprise optimized GALC open reading frame (ORF) sequences. The patent outlines vectors that utilize these sequences and methods for delivering the ORF to cells or subjects. This innovation aims to treat disorders associated with aberrant expression or activity of the GALC gene, such as Krabbe disease, also known as globoid cell leukodystrophy (GLD).

Career Highlights

Throughout his career, Erik Lykken has worked with prestigious institutions, including the University of North Carolina at Chapel Hill and the University of Pennsylvania. His research has contributed to advancements in gene therapy and the understanding of genetic disorders.

Collaborations

Lykken has collaborated with notable professionals in his field, including Steven Gray and Charles H. Vite. These partnerships have enhanced the impact of his research and innovations.

Conclusion

Erik Lykken's work exemplifies the intersection of innovation and healthcare, particularly in the realm of genetic therapies. His contributions continue to pave the way for advancements in treating genetic disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…